Survey on the SARS-CoV-2 serum antibody retention and health condition both before and after the SARS-CoV-2 vaccine introduction

JRCT ID: jRCT1061200057

Registered date:19/02/2021

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: severe acute respiratory syndrome coronavirus 2
• Date of first enrollment: 22/02/2021
• Target sample size: 2500
• Study type: Observational

Outcome(s)

• Primary Outcome: Transition of SARS-CoV-2 serum antibody titer both before and after the SARS-CoV-2 vaccine introduction

Secondary Outcome

Retention status of SARS-CoV-2 serum antibody before the SARS-CoV-2 vaccine introduction.
Health condition after the SARS-CoV-2 vaccine introduction

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both

Include criteria

School staff who wish to be vaccinated against the SARS-CoV-2
School staff who have agreed to participate in this study

• Exclude criteria: none

Related Information

• Primary Sponsor: Nakano Takashi
• Secondary Sponsor: Ohira Shin
• Source(s) of Monetary Support: Health and Labor Administration Promotion Research Project subsidy,School research expenses